Lokon Pharma is a biotech company in Sweden based on research from well renowned Uppsala University. They develop a new cancer medicine based on a virus that selectively kill tumor cells and activates the patients own immune system to attack the tumor. It is often described as an immunostimulatory gene therapy.

The incubators provides business development support, knowledge, and networks to innovative startups and fast-growing companies from all sectors.

Stardots develops a deep-tech Software-as-a-Medical-Device (SaMD) for Parkinson’s disease with the goal to increase quality of life and lower cost to society.Parkinson’s disease is complex, non-curable and costly, and causes great amount of suffering to the patient and their relatives. Since there are no readily available bio-markers, care is often subjective, unequal and not optimized. Stardots digital health approach is to offer progressive markers by mathematical modelling of symptoms (e.g., tremor) and using these objective estimators to optimize current treatment (e.g., deep brain stimulation). Our unique algorithms are based on many years of R&D at Uppsala university and tested in pilot studies at Uppsala University Hospital, and we have strong indications that similar approaches could be valid for other neurological diseases.

Deversify is a Swedish R&D company offering tech solutions in consumer health. We develop and commercialize mobile electronic devices and apps to monitor biomarkers for individualized health. Our products help people understand — and improve — their own health. Our mission is to act as a good force against today’s lifestyle diseases – such as obesity, diabetes, addictions, and cardiovascular disease.Deversify operates in growing consumer health markets which today in Europe and US alone are valued at over USD 5 billion. Our first product, the ketone breathalyzer Acetrack®, measures if your body is burning fat and is currently sold to health-tech consumers. Deversify is here to help you understand your wellbeing holistically – inside and out, from ketones to ECG.

Advanced therapies are increasingly being developed for patients in need, thereby putting pressure on the drug developers to produce qualified, effective, and safe matches. Immuneed combines our strong scientific knowledge with a versatile preclinical platform based on fresh, circulating human blood. Thereby, we provide our customers with a tailored solution in the early stage of development, enabling safe and effective drugs.

With the vision to eliminate anesthesia related complications, Senzime develop and commercialize systems powered by unique algorithms and sensors to monitor patient muscle function and electrical impulses, before, during and after surgery.

BioReperia helps every cancer patient to get the most effective treatment available, for their specific disease.BioReperia has developed a unique zebrafish tumor xenograft (ZTX™) platform that provides functional in-vivo data to evaluate treatment efficacy for tumor regression and metastasis inhibition in only 5 days.Our goal is to increase the speed and accuracy of preclinical drug development and clinical cancer treatment, enabling researchers and clinicians to select the drugs/drug candidates with the highest potential to succeed in less time.

The increase of antibiotic resistance is a global threat to human health. It is due to over- and miss-use of antibiotics, as a result of that doctors currently need to prescribe antibiotics before they know the resistance profile of the bacteria.Astrego’s technology provides such a resistance profile in 30 min and therfore allows prescription of effective,  non-broad spectrum, antibiotics at the point-of-care. Astrego’s first product targets urinary tract infection, which affects 100 milj women each year, and represents 15% of the antibiotic use in human medicine.

The ILP-technology is based on deploying chemokines, which until now have been regarded too unstable to be suitable as therapeutics. Ilya Pharma has overcome this problem by letting live lactic acid bacteria produce and deliver the human therapeutic chemokines on site in wounds in skin or e.g in the intestine acting like small bioreactors.

Pressure ulcer (bedsore) is a both painful and dangerous but unfortunately common medical injury. Among health care-related injuries, pressure ulcers are one of the most burdensome both economically and when it comes to human suffering, OECD reports.PU sensor has developed a method for evaluating a patient’s physiological condition regarding blood flow at pressure and thereby anticipate the risk of pressure ulcer and prevent it from appearing.